All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both SexNCT03392792
Regisry of the Stroke Patients in Assiut University Hospital
A study testing tissue plasminogen activator and thrombectomy in people with All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex, run by Assiut University.
Trial summary
Aim of the work To register all type of acute stroke admitted in Assiut university Hospital and assessment of their risk factor, morbidity and Mortality Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex
- What is being tested?
- tissue plasminogen activator and thrombectomy
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1 participants
- Where
- No sites listed yet
- Study dates
- 30 Dec 2018to 30 Dec 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- All patients with stroke aged ≥18 years of both sex
- Written consent was taken for all patient either from the patient himself of closes relative after explaning to them the type of treatment benefits and possible risks
Who cannot join
- Stroke due to metabolic causes as hypoglycemia liver, Renal failure and other metabolic causes
- Stroke due to Brain tumors
About this study
- Aim of the work To register all type of acute stroke admitted in Assiut university Hospital and assessment of their risk factor, morbidity and Mortality
- Being tested
- tissue plasminogen activator, thrombectomy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
tissue plasminogen activatorDrug
Also called rtpa
role of tissue plasminogen activator in patient with acute ischemic stroke having selective criteria for rTPA
thrombectomyProcedure or surgery
role of thrombectomy in patient with acute ischemic stroke
| Study group | Role | What they receive |
|---|---|---|
| tissue plasmnogen activator | Active comparator | Not described Receives: Drug: tissue plasminogen activator |
| thrombectoy | Active comparator | Not described Receives: Procedure: thrombectomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Registry of the stroke Patients in Assist University Hospital
Measured: one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2018
- Study start30 Dec 2018 (estimated)
- Primary completion30 Dec 2018 (estimated)
- Study completion30 Dec 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both SexStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 1 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Noura Abdel hakim abdel Mohsen, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03392792
- Sponsor's protocol ID
- Assiut u
- Status last verified
- Jan 2018
- First submitted
- 14 Dec 2017
- Last updated
- 8 Jan 2018
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jan 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Regisry of the Stroke Patients in Assiut University Hospital
- ClinicalTrials.gov ID
- NCT03392792
- Acronym / sponsor ID
- Assiut u
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 1 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 30 Dec 2018 (estimated)
- Primary completion
- 30 Dec 2018 (estimated)
- Study completion
- 30 Dec 2018 (estimated)
- First posted
- 8 Jan 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
- Aim of the work To register all type of acute stroke admitted in Assiut university Hospital and assessment of their risk factor, morbidity and Mortality
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| tissue plasmnogen activator | Active comparator | Drug: tissue plasminogen activator |
| thrombectoy | Active comparator | Procedure: thrombectomy |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- All patients with stroke aged ≥18 years of both sex
- Written consent was taken for all patient either from the patient himself of closes relative after explaning to them the type of treatment benefits and possible risks
Key exclusion criteria (2 listed)
- Stroke due to metabolic causes as hypoglycemia liver, Renal failure and other metabolic causes
- Stroke due to Brain tumors
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| tissue plasminogen activatorAlso: rtparole of tissue plasminogen activator in patient with acute ischemic stroke having selective criteria for rTPA | Drug | tissue plasmnogen activator |
| thrombectomyrole of thrombectomy in patient with acute ischemic stroke | Procedure or surgery | thrombectoy |
Primary outcome
Registry of the stroke Patients in Assist University Hospital
Time frame: one year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jan 2018.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing tissue plasminogen activator and thrombectomy in people with All Patients With Ischemic Cerebrovascular Stroke Aged ≥18 Years of Both Sex, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Registry of the stroke Patients in Assist University Hospital (time frame: one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2018.